Substituted 5H-Pyrimidol[5,4-b]indoles, method for the production thereof, and use thereof for treating non-solid malignant tumors of the blood-producing system

Details for Australian Patent Application No. 2007338313 (hide)

Owner The Medicines Company (Leipzig) GmbH

Inventors Daghish, Mohammed; Schulze, Alexander; Schuster, Maj; Ludwig, Alexander; DeAngelo, Joseph; Herrmann, Konrad; Letschert, Sven; Mugridge, Kenneth; Heinicke, Jochen; Reichelt, Claudia

Agent Spruson & Ferguson

Pub. Number AU-A-2007338313

PCT Pub. Number WO2008/077631

Priority 10 2006 062 203 22.12.06 DE

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

30 July 2009 PCT application entered the National Phase

  PCT publication WO2008/077631 Priority application(s): WO2008/077631

27 August 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Substituted 5H-pyrimidol[5,4-B]indoles, method for the production thereof, and use thereof for treating non-solid malignant tumors of the bloodproducing system

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338314-Automatic priorization of instances of medical care

2007338307-Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments